Evaluation of a urea/lactic acid-based topical keratolytic agent (ULABTKA) for prevention of capecitabine-induced hand and foot syndrome (HFS): NCCTG trial N05C5
   Google Scholar   
Citation:
J Clin Oncol vol 28 (15s) abstr 9017
Meeting Instance:
ASCO 2010
Year:
2010
Type:
Abstract
Sub type:
Poster General
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
SDC:
Yes
Parents:
None
Children:
841   2718  
Program:
CCP
Primary Committee:
Symptom Inter
Sec. Committees:
   
Pharmas:
 
Grants:
 
Corr. Author:
 
Authors:
                     
Networks:
 
Study
NCCTG-N05C5
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: